1. Home
  2. AMGN
  3. AMGN News

Latest Amgen Inc. (AMGN) News on November 25, 2025

AMGN

MT Newswires

a day ago

Alvotech Wins EU Approval for Osteoporosis, Cancer Bone Treatment Biosimilar

AMGN

MT Newswires

a day ago

Amgen Insider Sold Shares Worth $1,058,667, According to a Recent SEC Filing

Jim Cramer Says He “Should Have Been Recommending Regeneron”
AMGN

Insider Monkey

2 days ago

Jim Cramer Says He “Should Have Been Recommending Regeneron”

Amgen Shines As Medical Sector Benefits From Sector Rotation
AMGN

Investor's Business Daily

4 days ago

Amgen Shines As Medical Sector Benefits From Sector Rotation

Accord BioPharma, Inc. Announces FDA Approval of Denosumab Biosimilars OSVYRTI® (denosumab-desu) and JUBEREQ® (denosumab-desu)
AMGN

PR Newswire

5 days ago

Accord BioPharma, Inc. Announces FDA Approval of Denosumab Biosimilars OSVYRTI® (denosumab-desu) and JUBEREQ® (denosumab-desu)

This Drugmaker Is Too Cheap to Ignore. Why Bristol Is a Buy.
AMGN

Barrons.com

5 days ago

This Drugmaker Is Too Cheap to Ignore. Why Bristol Is a Buy.

Is Amgen Inc. (NASDAQ:AMGN) A High Quality Stock To Own?
AMGN

Simply Wall St.

5 days ago

Is Amgen Inc. (NASDAQ:AMGN) A High Quality Stock To Own?

AMGN

MT Newswires

6 days ago

Amgen Says FDA Granted Full Approval to Imdelltra to Treat Extensive Stage Small Cell Lung Cancer

FDA GRANTS FULL APPROVAL TO AMGEN'S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCER
AMGN

PR Newswire

6 days ago

FDA GRANTS FULL APPROVAL TO AMGEN'S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCER

It Might Be Time to Buy Stocks Again. Even Tech.
AMGN

Barrons.com

6 days ago

It Might Be Time to Buy Stocks Again. Even Tech.

Healthcare’s Momentum Gathers Steam. 3 Stocks With Bullish Charts.
AMGN

Barrons.com

6 days ago

Healthcare’s Momentum Gathers Steam. 3 Stocks With Bullish Charts.

AMGN

MT Newswires

6 days ago

HSBC Adjusts Price Target on Amgen to $381 From $343, Maintains Buy Rating

Renal Anemia Market Research Report 2025-2035, Competitive Analysis of Amgen, Sandoz, Pfizer, GlaxoSmithKline, Akebia Therapeutics, and Astellas Pharma
AMGN

GlobeNewswire

7 days ago

Renal Anemia Market Research Report 2025-2035, Competitive Analysis of Amgen, Sandoz, Pfizer, GlaxoSmithKline, Akebia Therapeutics, and Astellas Pharma

Microscopic Polyangiitis Market Research Report 2025-2035, Competitive Analysis of Roche, Amgen, Teva, Novartis, Baxter, Amerigen Pharma, InflaRx, Biogen, Pfizer, Celltrion
AMGN

GlobeNewswire

7 days ago

Microscopic Polyangiitis Market Research Report 2025-2035, Competitive Analysis of Roche, Amgen, Teva, Novartis, Baxter, Amerigen Pharma, InflaRx, Biogen, Pfizer, Celltrion

Jim Cramer Says Amgen (AMGN)’s New Drug Has Good Data
AMGN

Insider Monkey

7 days ago

Jim Cramer Says Amgen (AMGN)’s New Drug Has Good Data

The Weight-Loss Craze Is About to Mint a Trillion-Dollar Company
AMGN

The Wall Street Journal

7 days ago

The Weight-Loss Craze Is About to Mint a Trillion-Dollar Company

1 Unpopular Stock That Deserves a Second Chance and 2 We Avoid
AMGN

StockStory

7 days ago

1 Unpopular Stock That Deserves a Second Chance and 2 We Avoid

How the Latest Analyst Updates Are Shaping Amgen’s Evolving Growth Story
AMGN

Simply Wall St.

9 days ago

How the Latest Analyst Updates Are Shaping Amgen’s Evolving Growth Story

Amgen (AMGN): Evaluating Valuation After Strong June Performance and Share Price Gains
AMGN

Simply Wall St.

9 days ago

Amgen (AMGN): Evaluating Valuation After Strong June Performance and Share Price Gains

Jim Cramer on Amgen: “Why Not Go Buy That?”
AMGN

Insider Monkey

11 days ago

Jim Cramer on Amgen: “Why Not Go Buy That?”

AMGN

MT Newswires

11 days ago

Piper Sandler Adjusts Price Target on Amgen to $381 From $342, Maintains Overweight Rating

AMGN

MT Newswires

11 days ago

Amgen Insider Sold Shares Worth $2,317,071, According to a Recent SEC Filing

Why Amgen Stock Edged Past the Market on Thursday
AMGN

Motley Fool

12 days ago

Why Amgen Stock Edged Past the Market on Thursday

Jim Cramer Shows Confidence in Amgen
AMGN

Insider Monkey

12 days ago

Jim Cramer Shows Confidence in Amgen

Jim Cramer Notes Johnson & Johnson is “Really Bearing Down on High-Growth Pharma”
AMGN

Insider Monkey

12 days ago

Jim Cramer Notes Johnson & Johnson is “Really Bearing Down on High-Growth Pharma”

2 Supercharged Dividend Stocks to Buy Now
AMGN

Motley Fool

12 days ago

2 Supercharged Dividend Stocks to Buy Now

Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls
AMGN

The Fly

12 days ago

Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls

AMGN

MT Newswires

12 days ago

Scotiabank Initiates Amgen at Sector Outperform With $385 Price Target

Where Does Amgen Stand After 15% Surge and New Pipeline Approvals in 2025?
AMGN

Simply Wall St.

12 days ago

Where Does Amgen Stand After 15% Surge and New Pipeline Approvals in 2025?

Walt Disney and 15 More Non-AI Stocks Worth a Look
AMGN

Barrons.com

13 days ago

Walt Disney and 15 More Non-AI Stocks Worth a Look

Amgen’s (AMGN) Cholesterol Drug Is Very Important, Says JIm Cramer
AMGN

Insider Monkey

13 days ago

Amgen’s (AMGN) Cholesterol Drug Is Very Important, Says JIm Cramer

Dow on Pace to Clear 48,000 Closing Milestone
AMGN

Barrons.com

13 days ago

Dow on Pace to Clear 48,000 Closing Milestone

Amgen Inc.'s (NASDAQ:AMGN) high institutional ownership speaks for itself as stock continues to impress, up 14% over last week
AMGN

Simply Wall St.

13 days ago

Amgen Inc.'s (NASDAQ:AMGN) high institutional ownership speaks for itself as stock continues to impress, up 14% over last week

Why Amgen Stock Was a Nearly 5% Winner Today
AMGN

Motley Fool

14 days ago

Why Amgen Stock Was a Nearly 5% Winner Today

Government Shutdown Nears End, Lifting Investors’ Spirits—and Stocks
AMGN

The Wall Street Journal

14 days ago

Government Shutdown Nears End, Lifting Investors’ Spirits—and Stocks

Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know
AMGN

StockStory

14 days ago

Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know

Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know
AMGN

StockStory

14 days ago

Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know

Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know
AMGN

StockStory

14 days ago

Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know

Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know
AMGN

StockStory

14 days ago

Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know

Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know
AMGN

StockStory

14 days ago

Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know

Turn Therapeutics’ GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine
AMGN

GlobeNewswire

14 days ago

Turn Therapeutics’ GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine

AMGN

MT Newswires

14 days ago

Deutsche Bank Adjusts Amgen Price Target to $285 From $280, Maintains Hold Rating

Obesity Drugs Are About to Go Mass-Market
AMGN

The Wall Street Journal

14 days ago

Obesity Drugs Are About to Go Mass-Market

The Top 5 Analyst Questions From Amgen’s Q3 Earnings Call
AMGN

StockStory

14 days ago

The Top 5 Analyst Questions From Amgen’s Q3 Earnings Call

5 Revealing Analyst Questions From GoodRx’s Q3 Earnings Call
AMGN

StockStory

14 days ago

5 Revealing Analyst Questions From GoodRx’s Q3 Earnings Call

Merck’s Heart Pill Slashes Cholesterol Levels in Test Patients
AMGN

Barrons.com

15 days ago

Merck’s Heart Pill Slashes Cholesterol Levels in Test Patients

Are These 4 Biotech Stocks Set to Beat Q3 Earnings Estimates?
AMGN

Zacks

15 days ago

Are These 4 Biotech Stocks Set to Beat Q3 Earnings Estimates?

Beat the Market the Zacks Way: Amgen, Ciena, Fair Isaac in Focus
AMGN

Zacks

15 days ago

Beat the Market the Zacks Way: Amgen, Ciena, Fair Isaac in Focus

More Drugs to Fight High Cholesterol Are Emerging
AMGN

The Wall Street Journal

17 days ago

More Drugs to Fight High Cholesterol Are Emerging

Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60%
AMGN

Investor's Business Daily

17 days ago

Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60%

AMGEN'S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL
AMGN

PR Newswire

17 days ago

AMGEN'S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL

Amgen Inc. Just Beat EPS By 128%: Here's What Analysts Think Will Happen Next
AMGN

Simply Wall St.

17 days ago

Amgen Inc. Just Beat EPS By 128%: Here's What Analysts Think Will Happen Next

Jim Cramer on Amgen: “They Have A Lot of Good Medicines”
AMGN

Insider Monkey

17 days ago

Jim Cramer on Amgen: “They Have A Lot of Good Medicines”

Quantinuum Announces Commercial Launch of New Helios Quantum Computer that Offers Unprecedented Accuracy to Enable Generative Quantum AI (GenQAI)
AMGN

PR Newswire

19 days ago

Quantinuum Announces Commercial Launch of New Helios Quantum Computer that Offers Unprecedented Accuracy to Enable Generative Quantum AI (GenQAI)

Why Amgen (AMGN) Is Up 9.6% After Beating Q3 Expectations and Raising 2025 Guidance
AMGN

Simply Wall St.

19 days ago

Why Amgen (AMGN) Is Up 9.6% After Beating Q3 Expectations and Raising 2025 Guidance

Chronic Heart Failure Market Analysis and Forecast, 2025-2035, Featuring AstraZeneca, Bristol Myers Squibb, Cytokinetics, Bayer, Eli Lilly and Other Leading Players
AMGN

GlobeNewswire

19 days ago

Chronic Heart Failure Market Analysis and Forecast, 2025-2035, Featuring AstraZeneca, Bristol Myers Squibb, Cytokinetics, Bayer, Eli Lilly and Other Leading Players

AMGN

MT Newswires

19 days ago

Guggenheim Adjusts Price Target on Amgen to $305 From $288, Maintains Neutral Rating

AMGN

MT Newswires

19 days ago

Cantor Fitzgerald Adjusts Price Target on Amgen to $315 From $305, Maintains Neutral Rating

GoodRx Holdings Inc (GDRX) Q3 2025 Earnings Call Highlights: Strong Manufacturer Solutions ...
AMGN

GuruFocus.com

19 days ago

GoodRx Holdings Inc (GDRX) Q3 2025 Earnings Call Highlights: Strong Manufacturer Solutions ...

Amgen (AMGN) Profit Margins Surge to 19%, Challenging Bearish Market Narratives
AMGN

Simply Wall St.

19 days ago

Amgen (AMGN) Profit Margins Surge to 19%, Challenging Bearish Market Narratives

Stocks Rise Before the Open as Bond Yields Fall on Fed Rate-Cut Bets
AMGN

Barchart

19 days ago

Stocks Rise Before the Open as Bond Yields Fall on Fed Rate-Cut Bets

Amgen Inc. (NASDAQ:AMGN) Shares Could Be 49% Below Their Intrinsic Value Estimate
AMGN

Simply Wall St.

19 days ago

Amgen Inc. (NASDAQ:AMGN) Shares Could Be 49% Below Their Intrinsic Value Estimate

Company News for Nov 6, 2025
AMGN

Zacks

19 days ago

Company News for Nov 6, 2025

3 Large-Cap Stocks to Consider Right Now
AMGN

StockStory

19 days ago

3 Large-Cap Stocks to Consider Right Now

AMGN

MT Newswires

20 days ago

US Equity Indexes Rise With Treasury Yields as Valuation Concerns, Correction Warnings Slip to Rear View

Amgen Surges On Broad-Based Beat As Investors Zone In On Obesity
AMGN

Investor's Business Daily

20 days ago

Amgen Surges On Broad-Based Beat As Investors Zone In On Obesity

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Amgen, Cloudflare, Shopify, Super Micro Computer, Wingstop and More
AMGN

24/7 Wall St.

20 days ago

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Amgen, Cloudflare, Shopify, Super Micro Computer, Wingstop and More

AMGN

MT Newswires

20 days ago

Goldman Sachs Adjusts Price Target on Amgen to $400 From $405, Maintains Buy Rating

AMGN

MT Newswires

20 days ago

Morgan Stanley Adjusts Price Target on Amgen to $329 From $333, Maintains Equalweight Rating

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report
AMGN

Business Wire

20 days ago

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

Stocks Fall Pre-Bell as Investors Await ADP Employment Report, Fresh Corporate Earnings
AMGN

MT Newswires

20 days ago

Stocks Fall Pre-Bell as Investors Await ADP Employment Report, Fresh Corporate Earnings

AMGN

MT Newswires

20 days ago

Morgan Stanley Trims Price Target on Amgen to $329 From $333, Keeps Equalweight Rating

AMGN

Morningstar Research

20 days ago

Analyst Report: Amgen Inc.

Amgen Inc (AMGN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
AMGN

GuruFocus.com

20 days ago

Amgen Inc (AMGN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Stocks Down Pre-Bell Ahead of Latest Round of Corporate Earnings
AMGN

MT Newswires

21 days ago

Stocks Down Pre-Bell Ahead of Latest Round of Corporate Earnings

McDonald’s Earnings, Tariff Update, Musk Pay Vote: What to Watch This Week
AMGN

The Wall Street Journal

21 days ago

McDonald’s Earnings, Tariff Update, Musk Pay Vote: What to Watch This Week

AMGN

Argus Research

22 days ago

Market Digest: FHI, IEX, MCO, ORLY, UTHR, VLO, META, MDLZ

AMGN

MT Newswires

22 days ago

US Equity Investors to Focus on Earnings This Week as Government Shutdown Set to Become Longest in History

McDonald’s Earnings, Tariff Update, Musk Pay Vote: What to Watch This Week
AMGN

The Wall Street Journal

22 days ago

McDonald’s Earnings, Tariff Update, Musk Pay Vote: What to Watch This Week

Amgen Earnings: What To Look For From AMGN
AMGN

StockStory

22 days ago

Amgen Earnings: What To Look For From AMGN

The Bull Case For Royalty Pharma (RPRX) Could Change Following $2 Billion Debt Raise and New Royalty Deals
AMGN

Simply Wall St.

23 days ago

The Bull Case For Royalty Pharma (RPRX) Could Change Following $2 Billion Debt Raise and New Royalty Deals

Fed fallout, missing jobs numbers, and a busy earnings calendar: What to watch this week
AMGN

Yahoo Finance

23 days ago

Fed fallout, missing jobs numbers, and a busy earnings calendar: What to watch this week

A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases
AMGN

Simply Wall St.

23 days ago

A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases

Agilent Technologies (A): Evaluating Valuation as New CFO Adam Elinoff Joins to Drive Strategic Transformation
AMGN

Simply Wall St.

24 days ago

Agilent Technologies (A): Evaluating Valuation as New CFO Adam Elinoff Joins to Drive Strategic Transformation

SNAP benefits expire, open enrollment, earnings: What to Watch
AMGN

Yahoo Finance Video

25 days ago

SNAP benefits expire, open enrollment, earnings: What to Watch

AMGN

MT Newswires

25 days ago

S&P 500 Advances Weekly Amid Gains in Information Technology, Consumer Discretionary

AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND
AMGN

PR Newswire

25 days ago

AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND

Agilent selects Adam Elinoff as CFO
AMGN

MedTech Dive

25 days ago

Agilent selects Adam Elinoff as CFO

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
AMGN

Zacks

25 days ago

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025
AMGN

PR Newswire

25 days ago

AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025

Amgen Stock: Analyst Estimates & Ratings
AMGN

Barchart

25 days ago

Amgen Stock: Analyst Estimates & Ratings

CFOs On the Move: Week ending Oct. 31
AMGN

CFO.com

25 days ago

CFOs On the Move: Week ending Oct. 31

Amgen (AMGN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
AMGN

Zacks

a month ago

Amgen (AMGN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

Insiders At Amgen Sold US$12m In Stock, Alluding To Potential Weakness
AMGN

Simply Wall St.

a month ago

Insiders At Amgen Sold US$12m In Stock, Alluding To Potential Weakness

AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS
AMGN

PR Newswire

a month ago

AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS

Trump Administration Eases Approval Process for Biosimilar Drugs
AMGN

Barrons.com

a month ago

Trump Administration Eases Approval Process for Biosimilar Drugs

Amgen's Q3 Earnings in the Cards: Here's What to Expect
AMGN

Zacks

a month ago

Amgen's Q3 Earnings in the Cards: Here's What to Expect

Analysts Estimate Acadia Pharmaceuticals (ACAD) to Report a Decline in Earnings: What to Look Out for
AMGN

Zacks

a month ago

Analysts Estimate Acadia Pharmaceuticals (ACAD) to Report a Decline in Earnings: What to Look Out for

As Dow Hits Record, High-Yield Dogs of the Dow Still a Bargain
AMGN

24/7 Wall St.

a month ago

As Dow Hits Record, High-Yield Dogs of the Dow Still a Bargain

Earnings Preview: Amgen (AMGN) Q3 Earnings Expected to Decline
AMGN

Zacks

a month ago

Earnings Preview: Amgen (AMGN) Q3 Earnings Expected to Decline

Share on Social Networks: